Truist Securities Reiterates Buy Rating on Option Care Health (OPCH)
Truist Securities analyst David MacDonald reiterated a Buy rating and $30.00 price target on Option Care Health (NASDAQ: OPCH).The analyst ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)

